Clinical Trial Update: Clinical Study on Anti-tumor Effect Induced by Activated Primary Natural Killer（NK）Cells [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update for an activated primary natural killer cell therapy showing intent to assess anti-tumor effects in multiple cancers in early-phase study.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Colon Cancer
• Lung Cancer
• Ovarian Cancer
• Pancreatic Cancer

Snippet

Sponsor: Xuanwu Hospital, Beijing | Conditions: Lung Cancer, Breast Cancer | Phase 1, Phase 2 | Status: UNKNOWN